Bures sur Yvette, France

Micheline R Kergoat


 

 

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 83(Granted Patents)


Location History:

  • Bures sur Yvette, FR (2000 - 2017)
  • Les Ulis, FR (2019 - 2022)

Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: **Micheline R Kergoat: Innovator in Muscle Atrophy Treatment**

Introduction

Micheline R Kergoat, based in Bures-sur-Yvette, France, is a prominent inventor with a remarkable portfolio of 25 patents. Her innovative work primarily focuses on the use of tryptophan metabolites and other derivatives for treating muscle atrophy, a critical health concern in various populations, particularly the elderly and athletes.

Latest Patents

Among her latest innovations is a patent that emphasizes the use of tryptophan metabolites, specifically kynurenic acid, anthranilic acid, quinolinic acid, picolinic acid, and quinaldic acid. This invention targets the treatment of muscle atrophy, leveraging these metabolites to enhance or maintain muscle mass and strength in mammals. The solution aims to combat muscle loss, prevent symptoms of sarcopenia, and support recovery after intense physical activities.

Another significant patent focuses on oxime and alkoxy derivatives, designed for the treatment and prevention of muscle atrophy. This approach highlights their potential to limit muscle deterioration and bolster muscle growth in exercising mammals, thereby addressing age-related issues and the repercussions of immobility or medical treatment.

Career Highlights

Micheline has collaborated with notable organizations in her field, such as Merck Patent GmbH and Metabrain Research. Her work has significantly influenced advancements in the medical use of tryptophan and its derivatives, making her a key player in the realm of pharmaceutical innovations aimed at enhancing muscle health.

Collaborations

Throughout her career, Micheline R Kergoat has worked alongside esteemed colleagues, including Christine G Charon and Samer Elbawab. These collaborations have spurred innovative research and development in the medical field, further amplifying the impact of her patented inventions.

Conclusion

Micheline R Kergoat stands out as an influential inventor dedicated to tackling the challenges of muscle atrophy through her innovative patents. Her contributions not only benefit individuals facing muscle deterioration but also pave the way for future research and advancements in the field of muscle health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…